Methyl 3-bromo-4,5,6,7-tetrahydropyrazolo[1,5-a]pyridine-2-carboxylate
97%
- Product Code: 211268
CAS:
1448862-61-0
Molecular Weight: | 259.103 g./mol | Molecular Formula: | C₉H₁₁BrN₂O₂ |
---|---|---|---|
EC Number: | MDL Number: | MFCD26407241 | |
Melting Point: | Boiling Point: | ||
Density: | Storage Condition: | 2-8°C, sealed, dry |
Product Description:
Used as a key intermediate in the synthesis of pharmaceutical compounds, particularly in the development of kinase inhibitors and central nervous system agents. Its structure allows for selective modifications, making it valuable in medicinal chemistry for optimizing drug potency and bioavailability. Commonly employed in research settings to construct novel heterocyclic systems with potential therapeutic activity.
Sizes / Availability / Pricing:
Size | Availability | Price | Quantity |
---|---|---|---|
100mg | 10-20 days | £189.15 |
+
-
|
250mg | 10-20 days | £304.84 |
+
-
|
1g | 10-20 days | £940.93 |
+
-
|
Methyl 3-bromo-4,5,6,7-tetrahydropyrazolo[1,5-a]pyridine-2-carboxylate
Used as a key intermediate in the synthesis of pharmaceutical compounds, particularly in the development of kinase inhibitors and central nervous system agents. Its structure allows for selective modifications, making it valuable in medicinal chemistry for optimizing drug potency and bioavailability. Commonly employed in research settings to construct novel heterocyclic systems with potential therapeutic activity.
Mechanism | - |
Appearance | - |
Longevity | - |
Strength | - |
Storage | - |
Shelf Life | - |
Allergen(s) | - |
Dosage (Range) | - |
Recommended Dosage | - |
Dosage (Per Day) | - |
Recommended Dosage (Per Day) | - |
Mix Method | - |
Heat Resistance | - |
Stable in pH range | - |
Solubility | - |
Product Types | - |
INCI | - |
Purchase History for
Loading purchase history...
Cart
No products
Subtotal:
£0.00
£0.00
Total :